Clinical Trial Update: Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite [Phase 1]

View source ↗

Summary

This completed Phase 1 study assessed the effect of haemodialysis on the pharmacokinetics of ezogabine/retigabine and its N-acetyl metabolite in epilepsy patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Ezogabine/Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 1 | Status: COMPLETED